Abstract Submission

The HTLV Conference 2026 invites research papers of high quality in areas of HTLV research. Abstract submissions are peer reviewed for quality of research, scientific content, and logical presentation.

Presenting an abstract at the HTLV Conference is a unique opportunity for your work to gain exposure and recognition within the HTLV community.

The HTLV Conference will accept late poster abstracts for on-site presentation to 31st March 2026.

You can also submit an abstract for consideration as a virtual poster. Although these posters will not be presented, they will be visible in the conference app and abstract supplement if accepted. You must be registered as a virtual conference attendee in order to have a virtual poster accepted.

Abstract submission categories

Your abstract should be submitted to one of the following categories:

• Oncology and ATL
• Inflammation and HAM/TSP
• Infection/coinfection
• Infectivity
• Persistence
• Pathogenesis and animal models
• Policy/social impact/stigma
• Therapy
• Diagnosis
• Epidemiology
• Transmission Prevention
• Social determinants
• Viral Proteins and Molecular Biology
• Host pathogen interaction
• Elimination
• Neurological diseases
• Novel emerging technologies/topics
• Other retroviruses